Microvascular Therapeutics

Biotechnology Research • Tucson, Arizona, United States • 11-20 Employees

Company overview

Headquarters	1635 E 18th St, Tucson, Arizona 85719, US
Website	mvtpharma.com
NAICS	541714
SIC	873
Keywords	Imaging, Theranostics, Ultrasound Contrast Agent, Vascular Thrombosis
Founded	2009
Employees	11-20
Socials

Key Contact at Microvascular Therapeutics

Evan Unger

Founder And Ceo

Microvascular Therapeutics Email Formats

Microvascular Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@mvtpharma.com), used 71.4% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@mvtpharma.com	71.4%
{first initial}{last name}	jdoe@mvtpharma.com	28.6%

About Microvascular Therapeutics

Microvascular Therapeutics is a clinical stage biotechnology which pioneers in ultrasound contrast agents and theranostics. Microvascular Therapeutics (MVT) is developing a new improved ultrasound contrast agent MVT-100 via the 505(b)(2) pathway. The founders of MVT developed Definity®, the world’s #1 selling ultrasound contrast agent. Definity requires refrigerated temperature storage and has side effect of back pain. MVT-100 is a room temperature storage product and designed to eliminate the back pain. MVT has multiple theranostic products in its pipeline with multi-billion dollar market potential, the first one of which is expected to be regulated via the device pathway.

Microvascular Therapeutics revenue & valuation

Annual revenue	$1,000,000
Revenue per employee	$84,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,200,000
Total funding	$4,000,000

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

C-Suite

Manager

Employees by Department

Microvascular Therapeutics has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Microvascular Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-11-18	9	$4,000,000

Funding Insights

$4,000,000

Total funding amount

$4,000,000

Most recent funding amount

Number of funding rounds

Microvascular Therapeutics Tech Stack

Discover the technologies and tools that power Microvascular Therapeutics's digital infrastructure, from frameworks to analytics platforms.

GoDaddy

Hosting

Wix

Blogs

React

JavaScript frameworks

HSTS

Security

Frequently asked questions

Microvascular Therapeutics is located in Tucson, Arizona, US.

Microvascular Therapeutics was founded in 2009, making it 17 years old. The company has established itself as a significant player in its industry over this time.

Microvascular Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Microvascular Therapeutics has raised a total of $4,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Microvascular Therapeutics

Evan Unger

Founder And Ceo

4.8

40,000 users